Anebulo Pharmaceuticals, Inc.
ANEB- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001815974
No open-market purchases or sales by Anebulo Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding ANEB, Q2 2026
No superinvestor reported holding ANEB at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Anebulo Pharmaceuticals, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 26, 2024 (view filing)4:15 PM ET | Dec 23 | 3 days | English Aron R. and 1 otherDirector, 10% Owner | PPurchase | +10.1M | $0.99 | +$10.0M | +188.2%15.5M after | |
| Dec 21, 2021 (view filing)8:39 PM ET | Dec 17 | 4 days | English Aron R. and 1 otherDirector, 10% Owner, Other: See Explanation of Responses | PPurchaseCommon Stock, par value $0.001 per share | +400 | $6.59 | +$2.63K | 0.0%3.36M after | |
| Dec 16, 2021 (view filing)11:37 AM ET | Dec 14 | 2 days | English Aron R. and 1 otherDirector, 10% Owner, Other: See Explanation of Responses | PPurchaseCommon Stock, par value $0.001 per share | +412 | $5.90 | +$2.43K | 0.0%3.36M after | |
| Dec 3, 2021 (view filing)7:58 PM ET | Dec 3 | Same day | English Aron R. and 1 otherDirector, 10% Owner, Other: See Explanation of Responses | PPurchaseCommon Stock, par value $0.001 per share | +4.50K | $5.93 | +$26.7K | +0.1%3.36M after | |
| Dec 3, 2021 (view filing)11:16 AM ET | Dec 2 | 1 day | English Aron R. and 1 otherDirector, 10% Owner, Other: See Explanation Response | PPurchaseCommon Stock, par value $0.001 per share | +13.8K | $5.30 | +$73.3K | +0.4%3.36M after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Anebulo Pharmaceuticals, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding ANEB in 13F filings for Q2 2026.